AIMD Expands A-LRYNGO AI Laryngoscope Globally
Analysis based on 6 articles · First reported Sep 22, 2026 · Last updated Sep 24, 2026
The announcement is a single-company commercial milestone in the niche AI-assisted airway management segment, with no immediate read-through to broad equity, rate, or commodity markets. It modestly supports the medical device and healthcare AI theme, but AIMD is not publicly traded and the revenue impact of the cited deployments is not disclosed, so market-wide reaction should be minimal.
AIMD Inc., a Korean medical technology company spun out of Hanyang University research, announced the global expansion of A-LRYNGO, described as the world's first AI-guided video laryngoscope with real-time automatic glottis recognition. The device runs on-device AI that identifies the glottis and provides visual guidance during endotracheal intubation without an external server or recurring AI license fee, targeting clinicians and emergency personnel with limited intubation experience. The core AI technology was developed under a national R&D program supported by South Korea's South Korea — Ministry of Science and ICT and has moved from government-funded research to clinical evaluation and commercialization, with peer-reviewed publications in IEEE Access and Medicine. A-LRYNGO received dual Korean government recognition: designation as an Excellent R&D Innovative Product by the South Korea — Ministry of Science and ICT and selection as a Next-Generation World-Class Product. In South Korea the device is widely used across fire service and EMS organizations. Internationally, it is being evaluated at Mayo Clinic in the United States under a Korean government-supported overseas demonstration program, more than 200 units have been deployed across public hospitals in Uzbekistan, it has been adopted by the Quang Tri Department of Health in Vietnam, and it is used at the National Children's Hospital and four provincial public hospitals in Laos through a program supported by the South Korea — Korea International Cooperation Agency. On September 18, 2026, AIMD showcased A-LRYNGO at the KOICA AI Partners' Fair during the 19th Seoul ODA International Conference, jointly hosted by South Korea's Ministry of Foreign Affairs and KOICA, and plans to exhibit at MEDICA 2026 in Dusseldorf, Germany in November.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard